Sarepta Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 85 U.S.-traded ETFs. SRPT has around 7.1M shares in the U.S. ETF market. The largest ETF holder of SRPT is the ARK Genomic Revolution ETF (ARKG), with approximately 1.52M shares. Investors may also find of interest that the ETF with the largest allocation to SRPT stock is First Trust NYSE Arca Biotechnology Index Fund (FBT), with a portfolio weight of 3.51%. On average, U.S. ETFs allocate 0.27% of SRPT to their portfolios.
Additionally, SRPT is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SRPT as a holding is the ARK Genomic Revolution ETF (ARKG), with a return of 209.63%.